Orgenesis CEO Vered Caplan to Present at T1D Exchange Annual Meeting
October 20, 2016 10:19 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Oct 20, 2016) - Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and contract development and manufacturing company, announced that Orgenesis CEO, Vered...
Orgenesis CEO to Present at the 8th Annual Bioprocessing Summit
August 17, 2016 09:00 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 17, 2016) - Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that Orgenesis management...
Orgenesis and Atvio Biotech Launch Joint Venture for Gene and Cell Therapy Development Services
August 01, 2016 09:00 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 1, 2016) - Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and contract development and manufacturing company (the "Company" or "Orgenesis") has...
Orgenesis and CureCell Awarded Grant From the KORIL Fund for Diabetes Research and Development
June 07, 2016 09:00 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Jun 7, 2016) - Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and regenerative medicine company with a...
Orgenesis and Pall Corporation Receive $800,000 Grant From BIRD Foundation for Diabetes Research and Development
January 26, 2015 08:48 ET
|
Orgenesis Inc.
TEL AVIV, ISRAEL--(Marketwired - Jan 26, 2015) - Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and regenerative...
Orgenesis Receives Patent for Potential Cure for Type 1 Diabetes
October 15, 2014 07:00 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Oct 15, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received a...
Scott Carmer Named as CEO of Orgenesis North America
August 04, 2014 09:00 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - Aug 4, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of...
Orgenesis Signs Agreement With MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes
July 07, 2014 08:40 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Jul 7, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine today announced that its Belgian...
Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research
June 25, 2014 08:31 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Jun 25, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5...
Orgenesis Awarded Maryland Stem Cell Research Fund Grant
May 29, 2014 14:16 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - May 29, 2014) - Orgenesis Inc. (OTCQB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into...